Evaluation the effect of Granulocyte Colony Stimulating Factor on infertility

The comparing granulocyte colony stimulating factor , intra muscular and intra uterine form on fertilization at women with idiopathic infertility in intra uterine insemination.

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20200303046688N1

Enrollment

Registered

2020-05-26

Start date

2019-04-05

Completion date

Unknown

Last updated

2020-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

infertility. Female infertility, unspecified

Interventions

Intervention 1: Intervention group: sub cutaneous injection of 300 micro gram granulocyte with 0.5 milliliter in volume from Pooyesh Darou biopharmaceutical, made in iran in unique dose at trigger day

Eligibility

Sex/Gender

Female

Age

20 Years to 38 Years

Inclusion criteria

Inclusion criteria: Every patients with unexplained infertility

Exclusion criteria

Exclusion criteria: Pelvic anomaly Progressive endometriosis Azosperm sex partner Male factor infertility

Design outcomes

Primary

Measure	Time frame
Chemical pregnancy, clinical pregnancy. Timepoint: beta hcg seum test 2 weeks after IUI, sonographic evaluation 4 weeks after IUI. Method of measurement: biochemical serum test, sonography and FHR observation.	—

Secondary

Measure	Time frame
Endometrial tickness. Timepoint: trigger day. Method of measurement: sonography.;Chemical pregnancy. Timepoint: 2 weeks after IUI. Method of measurement: laboratory test.;Clinical pregnancy. Timepoint: 4 weeks after IUI. Method of measurement: sonography.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMaryam Azizi Cutenaei

Bandare-abbas University of Medical Sciences

Maryamazizikut86@gmail.com+98 76 3334 7001

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026